Author Response
- PMID: 36538290
- DOI: 10.1097/PTS.0000000000001099
Author Response
Conflict of interest statement
The authors disclose no conflict of interest.
Comment on
-
Spinal Cord Stimulator Complications Reported to the Australian Therapeutic Goods Administration.J Patient Saf. 2023 Mar 1;19(2):e53-e54. doi: 10.1097/PTS.0000000000001075. Epub 2022 Sep 28. J Patient Saf. 2023. PMID: 36170541 No abstract available.
References
-
- O’Connell NE, Ferraro MC, Gibson W, et al. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev . 2021;12:CD013756.
-
- Aljuboori Z, Meyer K, Sharma M, et al. Cost comparison among punctate midline myelotomy, intrathecal pain pump, and spinal cord epidural stimulator. Surg Neurol Int . 2020;11:25.
-
- Conduct a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS)—Letter to Health Care Providers | FDA. Available at: https://www.fda.gov/medical-devices/letters-health-care-providers/conduc... . Accessed August 15, 2022.
Publication types
LinkOut - more resources
Full Text Sources